Product Information

Avonex® (Interferon beta-1a)

Patient Information Leaflet:
UK ROI
Summary of Product Characteristics
UK ROI
European Public Assessment Report
UK ROI

Plegridy®
(Peginterferon beta-1a)

Patient Information Leaflet:
UK ROI
Summary of Product Characteristics
UK ROI
European Public Assessment Report
UK ROI

Tysabri®
(Natalizumab)

Patient Information Leaflet:
UK ROI
Summary of Product Characteristics
UK ROI
European Public Assessment Report
UK ROI

Fampyra®
(Fampridine)

Patient Information Leaflet:
UK ROI
Summary of Product Characteristics
UK ROI
European Public Assessment Report
UK ROI

Tecfidera®
(Dimethyl fumarate)

Patient Information Leaflet:
UK ROI
Summary of Product Characteristics
UK ROI
European Public Assessment Report
UK ROI

▼  This medicine is subject to additional monitoring. This will allow quick identification of new safety information.

 

MSP-PAN-0010a Date of preparation: September 2018